Treatment Effectiveness
User reported effectiveness ratings Duloxetine (Cymbalta) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Fibromyalgia | 4% | 26% | 25% | 34% | 11% | 244 |
| Neuropathy | 0% | 30% | 25% | 40% | 5% | 20 |
| Peripheral Neuropathy | 0% | 29% | 0% | 57% | 14% | 7 |
Side Effects
User-reported side effects of Duloxetine (Cymbalta)
| Side Effect | Percent of Reports Duloxetine (Cymbalta) |
|---|---|
| Diarrhea | 15% |
| Constipation | 27% |
| Dry Mouth | 46% |
| Heartburn | 18% |
| Itching | 18% |
| Stomach Pain | 18% |
| Changes in Sexual Desire or Ability | 49% |
| Decreased Appetite | 21% |
| Difficulty Urinating | 15% |
| Dizziness | 36% |
| Drowsiness | 39% |
| Excessive Sleeping | 24% |
| Facial Myofacial Pain | 20% |
| Increased Urination | 16% |
| Muscle Pain or Cramps | 24% |
| Sweating or Night Sweats | 42% |
| Turned Into Emotional Zombie/ Dissasociated | 0% |
| Uncontrollable Shaking of a Part of the Body | 16% |
| Vomiting | 14% |
| Weakness | 33% |
| Tiredness | 50% |
| Headache | 35% |
| Nausea | 38% |
Outcomes
Below is the degree of change seen after Duloxetine (Cymbalta) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Duloxetine (Cymbalta) Info
| Property | Value |
|---|---|
| Variable Name | Duloxetine (Cymbalta) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-04-06 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 93344 |